At UBS Bank, formerly Credit Suisse International, I perform and review month-end US GAAP and IFRS accounting for OTC derivatives and cash securities, prepare disclosures and notes to accounts, and support SOX control documentation and testing.
Previously at KPMG and EY, I managed statutory audits for TCS, Sun Pharmaceutical Industries, and Indira IVF Hospital, delivering Ind AS, IFRS, Companies Act, and IGAAS reporting. I bring experience in demerger accounting, consolidated financial statements, ICFR, tax audits, transfer pricing, and data analytics-driven audit delivery, alongside a track record of leading teams and earning Spotlight, Kudos, Rising Star, and Accelerator awards.
